Clinical efficacy of Camrelizumab combined with first-line chemotherapy in extensive-stage small-cell lung cancer

Autor: Zhang, Dou a, b, 1, Kong, Fanming a, b, 1, ∗, Gao, Fangfang c, Li, Longhui a, b, Liang, Yangyueying a, b, Yu, Minghui a, b, Zhao, Lu a, b, Wang, Na a, b, Jia, Yingjie a, b
Zdroj: In Heliyon 15 January 2024 10(1)
Databáze: ScienceDirect